Target intelligence / Profile preview

Ribosomal protein L29 pseudogene 19 (RPL29P19)

Target
RPL29P19
Molecular classification
Other (pseudogene; derived from ribosomal protein gene family)
01

Overview

RPL29P19 (ribosomal protein L29 pseudogene 19) is a processed pseudogene in the human genome derived from the functional ribosomal protein L29 (RPL29) gene. Pseudogenes like RPL29P19 result from the duplication or retrotransposition of functional gene sequences but usually lack the ability to produce active proteins, except in rare cases where novel regulatory or coding functions have evolved. In standard clinical, biological, and pharmacological contexts, RPL29P19 is neither expressed nor considered a biologically relevant molecule, receptor, drug target, or biomarker. Its parent gene, RPL29, encodes a peripheral membrane ribosomal protein involved in the structure and function of the large (60S) ribosomal subunit, but the pseudogene itself is essentially a genomic remnant without recognized impact on protein synthesis, disease, or medical intervention.

Other names
RPL29P19
02

Mechanism of action

None applicable. No mechanism, as no drugs target it.

03

Biological functions

None (for RPL29P19 specifically; pseudogenes generally do not have established biological functions unless otherwise reported)The functional parent gene, RPL29, encodes a ribosomal protein involved in protein synthesis and ribosome structure, but this pseudogene does not perform those roles
04

Disease associations

None (for RPL29P19 specifically)Disease associations may exist for the parent RPL29 gene, but not for this pseudogeneNo evidence suggests RPL29P19 involvement in disease
05

Safety considerations

None distinguishedNo safety, toxicity, or therapeutic challenges are relevant for RPL29P19.
06

Interacting drugs

None
07

Biomarkers

None documented for RPL29P19.

Beyond the preview

Go deeper on Ribosomal protein L29 pseudogene 19 (RPL29P19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L29 pseudogene 19 (RPL29P19).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call